|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006826,
umls-concept:C0022885,
umls-concept:C0077923,
umls-concept:C0086582,
umls-concept:C0205396,
umls-concept:C0229671,
umls-concept:C0231221,
umls-concept:C0392366,
umls-concept:C0681850,
umls-concept:C1274040,
umls-concept:C1522577,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C2349001,
umls-concept:C2697811
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2008-4-9
|
|
pubmed:abstractText |
Gastric cancer screening using the pepsinogen filter test is receiving wide recognition in Japan owing to convenience, freedom from discomfort or risk, efficiency, and economy. Because the long-term outcomes of cancer development in extensive atrophic gastritis detected by pepsinogen test are unclear, test-positive and test-negative subjects were investigated in a longitudinal cohort study.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1055-9965
|
|
pubmed:author |
pubmed-author:AriiKenjiK,
pubmed-author:EnomotoShotaroS,
pubmed-author:FujishiroMitsuhiroM,
pubmed-author:IchinoseMasaoM,
pubmed-author:IguchiMikitakaM,
pubmed-author:MagariHirohitoH,
pubmed-author:MoharaOsamuO,
pubmed-author:MukoubayashiChizuC,
pubmed-author:OhataHiroshiH,
pubmed-author:OkaMasashiM,
pubmed-author:TakeshitaTatsuyaT,
pubmed-author:TamaiHideyukiH,
pubmed-author:UtsunomiyaHirotoshiH,
pubmed-author:YanaokaKimihikoK,
pubmed-author:YoshimuraNorikoN
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
838-45
|
|
pubmed:meshHeading |
pubmed-meshheading:18398025-Adult,
pubmed-meshheading:18398025-Atrophy,
pubmed-meshheading:18398025-Follow-Up Studies,
pubmed-meshheading:18398025-Humans,
pubmed-meshheading:18398025-Incidence,
pubmed-meshheading:18398025-Japan,
pubmed-meshheading:18398025-Male,
pubmed-meshheading:18398025-Mass Screening,
pubmed-meshheading:18398025-Middle Aged,
pubmed-meshheading:18398025-Pepsinogen A,
pubmed-meshheading:18398025-Proportional Hazards Models,
pubmed-meshheading:18398025-Risk Factors,
pubmed-meshheading:18398025-Stomach Neoplasms,
pubmed-meshheading:18398025-Tumor Markers, Biological
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males.
|
|
pubmed:affiliation |
Department of Gastroenterology, School of Medicine, Wakayama Medical University, Wakayama, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
